WITHDRAWN: Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG

Affiliations

• ¹ Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom. Electronic address: sjoerd.Rijpkema@nibsc.org.
• ² Biostatistics Group, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom.
• ³ Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom.
• ⁴ Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
• ⁵ Institute for Biological Product Control, National Institute for Food and Drug Control, No.2 Tiantan Xili, Beijing, People's Republic of China.
• ⁶ Clinical Trial Department, Surveillance & Clinical Trial Division, Bio Farma, Jl.Pasteur No.28, Bandung Indonesia.
• ⁷ Clinical Immunology, International Vaccine Institute, SNU Research Park, 1 Kwanak-Ro, Kwanak-Gu, Seoul, Republic of Korea.
• ⁸ R&D, Biological E. Ltd, MN Park, Genome Valley, Shameerpet, Hyderabad, 500078, Telangana, India.
• ⁹ Quality Operations, Bharat Biotech International Ltd, Genome Valley, Shameerpet, Hyderabad, 500078, Telangana, India.
• ¹⁰ Center for Vaccine Development, University of Maryland Baltimore, 685 West Baltimore Street, Room 480, Baltimore, MD, USA.